Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

Additive Effects of PS1 and APP Mutations on Secretion of the 42-Residue Amyloid β-Protein

Humans harboring missense mutations in the presenilin 1 (PS1) gene undergo progressive cerebral deposition of the 42-residue amyloid β-protein (Aβ42) at an early age and develop severe Alzheimer's disease. Aβ42is selectively elevated in the conditioned media of cells expressing mutant but not w...

Full description

Bibliographic Details
Main Authors:	Martin Citron, Christopher B. Eckman, Thekla S. Diehl, Chris Corcoran, Beth L. Ostaszewski, Weiming Xia, Georges Levesque, Peter St. George Hyslop, Steven G. Younkin, Dennis J. Selkoe
Format:	Article
Language:	English
Published:	Elsevier 1998-08-01
Series:	Neurobiology of Disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996198901838

Similar Items

FAD Mutations in Presenilin-1 or Amyloid Precursor Protein Decrease the Efficacy of a γ-Secretase Inhibitor: Evidence for Direct Involvement of PS1 in the γ-Secretase Cleavage Complex
by: Weiming Xia, et al.
Published: (2000-12-01)

Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
by: Liding Zhang, et al.
Published: (2021-08-01)

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice
by: Freeman Melissa J, et al.
Published: (2005-02-01)

LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice[S]
by: Sophie Stukas, et al.
Published: (2014-08-01)

Icaritin, an inhibitor of beta-site amyloid cleaving enzyme-1, inhibits secretion of amyloid precursor protein in APP-PS1-HEK293 cells by impeding the amyloidogenic pathway
by: Fei Feng, et al.
Published: (2019-12-01)

Aged wild-type and APP, PS1, and APP+PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load
by: A. Gruart, et al.
Published: (2008-06-01)

VIP enhances phagocytosis of fibrillar beta-amyloid by microglia and attenuates amyloid deposition in the brain of APP/PS1 mice.
by: Min Song, et al.
Published: (2012-01-01)

Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of β-amyloid peptide
by: Jian-Xiang Zhang, et al.
Published: (2019-12-01)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
by: Xiao-bo Yang, et al.
Published: (2022-01-01)

SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice
by: Qiong Wu, et al.
Published: (2020-06-01)

Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
by: Joseph F. Poduslo, et al.
Published: (1999-06-01)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer's disease.
by: Diana Klakotskaia, et al.
Published: (2018-01-01)

Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
by: Pravin Yeapuri, et al.
Published: (2023-12-01)

Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice
by: Adrian C. Lo, et al.
Published: (2013-02-01)

Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice
by: Jukka Puoliväli, et al.
Published: (2002-04-01)

Mapping the APP/Presenilin (PS) Binding Domains: The Hydrophilic N-Terminus of PS2 Is Sufficient for Interaction with APP and Can Displace APP/PS1 Interaction
by: Laurent Pradier, et al.
Published: (1999-02-01)

Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain Tissue
by: Marcia B. Podlisny, et al.
Published: (1997-01-01)

siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
by: Kandimalla Ramesh JL, et al.
Published: (2012-01-01)

Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina
by: Laura Carrero, et al.
Published: (2023-10-01)

Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease
by: Alessandro Leparulo, et al.
Published: (2019-12-01)

Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
by: Thomas van Groen, et al.
Published: (2006-09-01)

Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
by: Nikisha Carty, et al.
Published: (2013-01-01)

Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
by: Yanxing Chen, et al.
Published: (2021-02-01)

ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice
by: Emily B. Button, et al.
Published: (2019-05-01)

Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo
by: Sonya Brijbassi, et al.
Published: (2007-02-01)

YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
by: Zheng-Yi Li, et al.
Published: (2017-04-01)

Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions
by: Ou Qiao, et al.
Published: (2021-06-01)

Neurogenesis, neurodegeneration, interneuron vulnerability and amyloid-β in the olfactory bulb of APP/PS1 mouse model of Alzheimer’s disease
by: Carlos eDe La Rosa Prieto, et al.
Published: (2016-05-01)

Gallic acid disruption of Aβ1–42 aggregation rescues cognitive decline of APP/PS1 double transgenic mouse
by: Mei Yu, et al.
Published: (2019-04-01)

If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
by: Christian Haass, et al.
Published: (2022-07-01)

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis
by: Raquel Sanchez-Varo, et al.
Published: (2021-11-01)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
by: Pengcheng Geng, et al.
Published: (2018-07-01)

Transauricular vagal nerve stimulation at 40Hz attenuates hippocampal amyloid load in 6-month-old APP/PS mice
by: Yutian Yu, et al.
Published: (2021-11-01)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP
by: Roberts, HL, et al.
Published: (2017)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
by: Hazel L Roberts, et al.
Published: (2017-01-01)

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
by: Meilandt, William J., et al.
Published: (2022)

Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
by: Meilandt, William J, et al.
Published: (2021)

Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
by: Tushar Arora, et al.
Published: (2023-01-01)

The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
by: Kelly H. Forest, et al.
Published: (2021-04-01)

Immunocytochemical Characterization of Alzheimer’s Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
by: Ivan Carrera, et al.
Published: (2014-03-01)